Selected research
Industry Growth & Trends
Global Codeine Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Codeine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Codeine Drug market include Apotex, Aristo Pharma GmbH, Cipla, Hikma, Laboratoire Riva, Lannett Company, Mallinckrodt, Medreich and Pharmaceutical Associates, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Codeine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Codeine Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Codeine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Codeine Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Codeine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Codeine Drug Market by Company
Apotex
Aristo Pharma GmbH
Cipla
Hikma
Laboratoire Riva
Lannett Company
Mallinckrodt
Medreich
Pharmaceutical Associates
Sanofi Aventis
Taiji
Viatris
Novartis
Johnson & Johnson
TEVA
Codeine Drug Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications Codeine
Codeine Drug Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Codeine Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications Codeine
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- Apotex
- Aristo Pharma GmbH
- Cipla
- Hikma
- Laboratoire Riva
- Lannett Company
- Mallinckrodt
- Medreich
- Pharmaceutical Associates
- Sanofi Aventis
- Taiji
- Viatris
- Novartis
- Johnson & Johnson
- TEVA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Codeine Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Codeine Drug Market Size by Region (2021-2032)
- 1.4.1 Global Codeine Drug Market Size by Region (2021-2026)
- 1.4.2 Global Codeine Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Codeine Drug Market Size (2021-2032)
- 1.5.1 North America Codeine Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Codeine Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Codeine Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Codeine Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Codeine Drug Market Size Growth Rate (2021-2032)
2 Codeine Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Single-ingredient Codeine
- 2.1.2 Multi-ingredient Medications Codeine
- 2.2 Global Codeine Drug Market Size by Type
- 2.2.1 Global Codeine Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Codeine Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Codeine Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Codeine Drug Market Size by Regions
- 2.3.1 North America Codeine Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Codeine Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Codeine Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Codeine Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Codeine Drug Market Size Breakdown by Type (2021-2026)
3 Codeine Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Narcotic Analgesic
- 3.1.2 Antitussive
- 3.1.3 Others
- 3.2 Global Codeine Drug Market Size by Application
- 3.2.1 Global Codeine Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Codeine Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Codeine Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Codeine Drug Market Size by Regions
- 3.3.1 North America Codeine Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Codeine Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Codeine Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Codeine Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Codeine Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Codeine Drug Industry Trends
- 4.2 Codeine Drug Industry Drivers
- 4.3 Codeine Drug Industry Opportunities and Challenges
- 4.4 Codeine Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Codeine Drug Revenue (2021-2026)
- 5.2 Global Codeine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Codeine Drug Key Company Headquarters & Area Served
- 5.4 Global Codeine Drug Company, Product Type & Application
- 5.5 Global Codeine Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Codeine Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Codeine Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Codeine Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Apotex
- 6.1.1 Apotex Company Information
- 6.1.2 Apotex Business Overview
- 6.1.3 Apotex Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Apotex Codeine Drug Product Portfolio
- 6.1.5 Apotex Recent Developments
- 6.2 Aristo Pharma GmbH
- 6.2.1 Aristo Pharma GmbH Company Information
- 6.2.2 Aristo Pharma GmbH Business Overview
- 6.2.3 Aristo Pharma GmbH Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aristo Pharma GmbH Codeine Drug Product Portfolio
- 6.2.5 Aristo Pharma GmbH Recent Developments
- 6.3 Cipla
- 6.3.1 Cipla Company Information
- 6.3.2 Cipla Business Overview
- 6.3.3 Cipla Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cipla Codeine Drug Product Portfolio
- 6.3.5 Cipla Recent Developments
- 6.4 Hikma
- 6.4.1 Hikma Company Information
- 6.4.2 Hikma Business Overview
- 6.4.3 Hikma Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Hikma Codeine Drug Product Portfolio
- 6.4.5 Hikma Recent Developments
- 6.5 Laboratoire Riva
- 6.5.1 Laboratoire Riva Company Information
- 6.5.2 Laboratoire Riva Business Overview
- 6.5.3 Laboratoire Riva Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Laboratoire Riva Codeine Drug Product Portfolio
- 6.5.5 Laboratoire Riva Recent Developments
- 6.6 Lannett Company
- 6.6.1 Lannett Company Company Information
- 6.6.2 Lannett Company Business Overview
- 6.6.3 Lannett Company Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Lannett Company Codeine Drug Product Portfolio
- 6.6.5 Lannett Company Recent Developments
- 6.7 Mallinckrodt
- 6.7.1 Mallinckrodt Company Information
- 6.7.2 Mallinckrodt Business Overview
- 6.7.3 Mallinckrodt Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Mallinckrodt Codeine Drug Product Portfolio
- 6.7.5 Mallinckrodt Recent Developments
- 6.8 Medreich
- 6.8.1 Medreich Company Information
- 6.8.2 Medreich Business Overview
- 6.8.3 Medreich Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Medreich Codeine Drug Product Portfolio
- 6.8.5 Medreich Recent Developments
- 6.9 Pharmaceutical Associates
- 6.9.1 Pharmaceutical Associates Company Information
- 6.9.2 Pharmaceutical Associates Business Overview
- 6.9.3 Pharmaceutical Associates Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Pharmaceutical Associates Codeine Drug Product Portfolio
- 6.9.5 Pharmaceutical Associates Recent Developments
- 6.10 Sanofi Aventis
- 6.10.1 Sanofi Aventis Company Information
- 6.10.2 Sanofi Aventis Business Overview
- 6.10.3 Sanofi Aventis Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Sanofi Aventis Codeine Drug Product Portfolio
- 6.10.5 Sanofi Aventis Recent Developments
- 6.11 Taiji
- 6.11.1 Taiji Company Information
- 6.11.2 Taiji Business Overview
- 6.11.3 Taiji Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Taiji Codeine Drug Product Portfolio
- 6.11.5 Taiji Recent Developments
- 6.12 Viatris
- 6.12.1 Viatris Company Information
- 6.12.2 Viatris Business Overview
- 6.12.3 Viatris Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Viatris Codeine Drug Product Portfolio
- 6.12.5 Viatris Recent Developments
- 6.13 Novartis
- 6.13.1 Novartis Company Information
- 6.13.2 Novartis Business Overview
- 6.13.3 Novartis Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Novartis Codeine Drug Product Portfolio
- 6.13.5 Novartis Recent Developments
- 6.14 Johnson & Johnson
- 6.14.1 Johnson & Johnson Company Information
- 6.14.2 Johnson & Johnson Business Overview
- 6.14.3 Johnson & Johnson Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Johnson & Johnson Codeine Drug Product Portfolio
- 6.14.5 Johnson & Johnson Recent Developments
- 6.15 TEVA
- 6.15.1 TEVA Company Information
- 6.15.2 TEVA Business Overview
- 6.15.3 TEVA Codeine Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 TEVA Codeine Drug Product Portfolio
- 6.15.5 TEVA Recent Developments
7 North America
- 7.1 North America Codeine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Codeine Drug Market Size by Country (2021-2026)
- 7.3 North America Codeine Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Codeine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Codeine Drug Market Size by Country (2021-2026)
- 8.3 Europe Codeine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Codeine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Codeine Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Codeine Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Codeine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Codeine Drug Market Size by Country (2021-2026)
- 10.3 South America Codeine Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Codeine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Codeine Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Codeine Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst